Transaction · 0002120886-26-000001

Knotnerus Tim Jasper

Knotnerus Tim Jasper, CEO, reported an open-market or private purchase at AgomAb Therapeutics NV involving 5000.000000 shares for an estimated $43500.00. Reported holdings after the transaction were 21823.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
AGMBAgomAb Therapeutics NV
Filing timeOct 07
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded29.72%Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 16,823 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AGMB price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AGMB since 2026-10-07Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0002120886-26-000001
Common shares
Transaction date
Oct 06, 2026
Filed Oct 07, 2026, 12:06 PM · 1d delay
Shares
5.00k sh
$8.70 per share
Estimated value
$43.5k
Computed from shares × price
Holdings after
21.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CEO Buy Cluster Buy Director Buy Direct Ownership
+48score
Filing-only score

+48

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

  2. F2

    Shares held by TJK Life Sciences B.V. ("TJK Life Sciences"). The Reporting Person exercises voting and dispositive power over the shares held by TJK Life Sciences and disclaims beneficial ownership of…

Original filing · 0002120886-26-000001
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AGMB